Halozyme Therapeutics, Inc.
2014 Q1 - 2025 Q4 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 15,976 | 0.0% | 237,379 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 18,300 | 0.0% | 249,526 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 12,263 | 0.0% | 235,728 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 14,403 | 0.0% | 225,712 | 3/31/2025 |
| 2024 Q4 | 4/23/2025 | 10,216 | 0.0% | 213,687 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 13,100 | 0.0% | 228,859 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 12,649 | 0.0% | 241,568 | 6/30/2024 |
| 2024 Q1 | 4/30/2024 | 9,485 | 0.0% | 233,173 | 3/31/2024 |
| 2023 Q4 | 2/1/2024 | 8,877 | 0.0% | 240,178 | 12/31/2023 |
| 2023 Q3 | 11/2/2023 | 9,560 | 0.0% | 250,251 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 8,945 | 0.0% | 247,980 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 14,138 | 0.0% | 370,213 | 3/31/2023 |
| 2022 Q4 | 2/8/2023 | 21,607 | 0.0% | 379,734 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 12,283 | 0.0% | 310,657 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 11,622 | 0.0% | 264,136 | 6/30/2022 |
| 2022 Q1 | 5/4/2022 | 11,396 | 0.0% | 285,769 | 3/31/2022 |
| 2021 Q4 | 2/10/2022 | 12,449 | 0.0% | 309,604 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 12,824 | 0.0% | 315,235 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 14,302 | 0.0% | 314,959 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 13,909 | 0.0% | 333,621 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 14,531 | 0.0% | 340,223 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 8,213 | 0.0% | 312,518 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 8,134 | 0.0% | 303,383 | 6/30/2020 |
| 2020 Q1 | 5/12/2020 | 5,411 | 0.0% | 300,774 | 3/31/2020 |
| 2019 Q4 | 1/27/2020 | 9,560 | 0.0% | 539,202 | 12/31/2019 |
| 2014 Q1 | 4/18/2014 | 1,962 | 0.0% | 236,700 | 3/31/2014 |